Breaking News, Promotions & Moves

Syntegon Group Appoints Peter Hackel as CFO

Will assume office from the beginning of 2023.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Syntegon Group, a global supplier of processing and packaging technology, intends to appoint Peter Hackel as member of the executive board at the beginning of 2023. In his new position, as chief financial officer, Hackel will be responsible for Finance & Controlling, Foreign Trade and IT of Syntegon. He will be located at Beringen, Switzerland.

Hackel is a well-rounded, highly accomplished executive, experienced within sales as well as in finance and in this capacity has served as chief financial officer in different companies for more than nine years. He started his career with McKinsey & Company Inc. followed by Geistlich Pharma AG, Oerlikon Corporation AG and most recently at Straumann Holding AG, where he has contributed to the positive development of the company as group chief financial officer and member of the group executive management board since 2014. He holds a Ph.D. degree in molecular biology from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland, and studied business administration at the University of Hagen, Germany.

“We are very pleased to have won Peter Hackel, an extremely experienced and successful manager, for Syntegon. Almost two decades of management expertise in operations, finance and business management in different industries and an international network are excellent prerequisites to further advance the successful development of Syntegon,” Michael Grosse, CEO of the Syntegon Group.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters